Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report

Authors :: Colaci, Michele
Sebastiani, Marco
Sandri, Gilda
Meacci, Marisa
Ferri, Clodoveo
Source :: Case Reports in Infectious Diseases.
Publication Year :: 2011
Publisher :: Hindawi Publishing Corporation, 2011.
Abstract: TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.

Full Text Access

Tools